Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Heart Failure Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10741-017-9657-9PMID 29038991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.

  2019cited by this paper
• Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

  2018cited by this paper
• Heart Failure as a Risk Factor for Stroke

  2018cited by this paper
• Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.

  2017cited by this paper
• Reverse atrial electrical remodeling induced by cardiac resynchronization therapy.

  2017cited by this paper
• Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy

  2017cited by this paper
• 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.

  2017cited by this paper
• Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.

  2017cited by this paper
• [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS].

  2016cited by this paper
• Perioperative Rosuvastatin in Cardiac Surgery.

  2016cited by this paper
• Perioperative Rosuvastatin in Cardiac Surgery.

  2016cited by this paper
• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

  2016cited by this paper
• EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication☆☆☆

  2016cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction

  2016cited by this paper
• EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.

  2016cited by this paper
• Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial

  2016cited by this paper
• Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy

  2015cited by this paper
• Inositol‐1,4,5‐trisphosphate induced Ca2+ release and excitation–contraction coupling in atrial myocytes from normal and failing hearts

  2015cited by this paper
• European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

  2015cited by this paper
• Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter

  2015cited by this paper
• Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials.

  2015cited by this paper
• Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.

  2015cited by this paper
• Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes.

  2014cited by this paper
• Calcium and IP3 dynamics in cardiac myocytes: experimental and computational perspectives and approaches

  2014cited by this paper
• Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation

  2014cited by this paper
• The CABANA trial.

  2014cited by this paper
• Left Atrium in Heart Failure With Preserved Ejection Fraction: Structure, Function, and Significance

  2014cited by this paper
• A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial)

  2014cited by this paper
• Atrial Fibrillation Therapy Now and in the Future: Drugs, Biologicals, and Ablation

  2014cited by this paper
• Left atrial size and function: role in prognosis.

  2014cited by this paper
• Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.

  2013cited by this paper
• Atrial Fibrillation Patterns and Risks of Subsequent Stroke, Heart Failure, or Death in the Community

  2013cited by this paper
• Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction: A Community-Based Study

  2013cited by this paper
• A functional role for transverse (t-) tubules in the atria.

  2013cited by this paper
• A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.

  2013cited by this paper
• Reference laboratory values for digoxin following publication of Digitalis Investigation Group (DIG) trial data.

  2013cited by this paper
• Mineralocorticoid receptor antagonists and mortality in heart failure with concurrent atrial fibrillation.

  2012cited by this paper
• Mineralocorticoid Receptor Antagonists and Cardiovascular Mortality in Patients With Atrial Fibrillation and Left Ventricular Dysfunction: Insights From the Atrial Fibrillation and Congestive Heart Failure Trial

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation.

  2012cited by this paper
• Complex fractionated atrial electrograms: a worthwhile target for ablation of atrial fibrillation?

  2011cited by this paper
• Pathophysiological mechanisms of atrial fibrillation: a translational appraisal.

  2011cited by this paper
• Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators.

  2011cited by this paper
• Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

  2010cited by this paper
• Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.

  2010cited by this paper
• Lenient versus strict rate control in patients with atrial fibrillation.

  2010cited by this paper
• Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

  2009cited by this paper
• Catheter Ablation versus Standard Conventional Treatment in Patients with Left Ventricular Dysfunction and Atrial Fibrillation (CASTLE‐AF) ‐ Study Design

  2009cited by this paper
• Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management

  2009cited by this paper
• Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.

  2009cited by this paper
• Rhythm control versus rate control for atrial fibrillation and heart failure.

  2008cited by this paper
• Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

  2008cited by this paper
• Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation

  2007cited by this paper
• Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

  2006cited by this paper
• Diuretics for heart failure.

  2006cited by this paper
• Atrial fibrillation: Choosing an antiarrhythmic drug

  2006cited by this paper
• Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.

  2006cited by this paper
• Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

  2006cited by this paper
• Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

  2006cited by this paper
• Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

  2005cited by this paper
• Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1

  2004cited by this paper
• Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

  2004cited by this paper
• Catheter ablation for atrial fibrillation in congestive heart failure.

  2004cited by this paper
• The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

  2004cited by this paper
• Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics

  2004cited by this paper
• Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor

  2004cited by this paper
• Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.

  2003cited by this paper
• Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

  2003cited by this paper
• Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

  2003cited by this paper
• Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

  2003cited by this paper
• Heart Failure Complicated by Atrial Fibrillation: Mechanistic, Prognostic, and Therapeutic Implications

  2003cited by this paper
• Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation: Early Clinical Experience

  2002cited by this paper
• A comparison of rate control and rhythm control in patients with atrial fibrillation.

  2002cited by this paper
• Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing.

  2002cited by this paper
• New ideas about atrial fibrillation 50 years on

  2002cited by this paper
• Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure

  2001cited by this paper
• Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure

  2001cited by this paper
• Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience.

  2000influential reference
• Effects of experimental heart failure on atrial cellular and ionic electrophysiology.

  2000cited by this paper
• Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

  1999cited by this paper
• Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.

  1998cited by this paper
• Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.

  1997cited by this paper
• Calcium Currents in Diseased Human Cardiac Cells

  1995cited by this paper
• The Maze procedure: a new treatment for atrial fibrillation.

  1992cited by this paper
• Diuretics in heart failure.

  1986cited by this paper
• Importance of the "atrial kick" in determining the effective mitral valve orifice area in mitral stenosis.

  1986cited by this paper
• The Relationship of Human Atrial Cellular Electrophysiology to Clinical Function and Ultrastructure

  1983cited by this paper
• Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.

  1983cited by this paper
• CHOOSING AN ANTIARRHYTHMIC DRUG

  1978cited by this paper
• Left atrial transport function in myocardial infarction. Importance of its booster pump function.

  1975cited by this paper
• Essential hypertension: renin and aldosterone, heart attack and stroke.

  1972cited by this paper
• Epidemiological approaches to heart disease: the Framingham Study.

  1951cited by this paper

• 2025 THRS Expert Consensus of Imaging Assessment in Atrial Fibrillation. Developed by the Task Force of the Taiwan Heart Rhythm Society (THRS) Imaging Committee. Endorsed by the Taiwan Society of Cardiology (TSOC).

  2025cites this paper
• Heart Failure and the Non-Resolution of Atrial Thrombus Detected in Anticoagulated Patients with Non-Valvular Atrial Fibrillation

  2025cites this paper
• Safety and Efficacy of Shensong Yangxin Capsule Combined With Conventional Drugs for Atrial Fibrillation: A Meta‐Analysis

  2025cites this paper
• Targeting atrial fibrillation in HFpEF: the emerging role of pulsed field ablation

  2025cites this paper
• Spectral analysis of heart rate variability in patients with newly diagnosed atrial fibrillation

  2024cites this paper
• Optimization-enabled deep convolutional neural network with multiple features for cardiac arrhythmia classification using ECG signals

  2024cites this paper
• Arrhythmias and cardiac MRI associations in patients with established cardiac dystrophinopathy

  2024cites this paper
• Atrial Fibrillation Ablation in Heart Failure and Preserved Ejection Fraction: An Observational Study of Risk Factors for Heart Failure Hospitalization

  2024cites this paper
• Nrf2 Ameliorates Atrial Fibrosis During Antithrombotic Therapy for Atrial Fibrillation by Modulating CYP2C9 Activity

  2024cites this paper
• Development of a Nomogram That Predicts the Risk of Atrial Fibrillation in Patients with Coronary Heart Disease

  2024cites this paper
• Clinical efficacy and safety of Shensong Yangxin capsule-antiarrhythmic drug combination for paroxysmal atrial fibrillation: A meta-analysis of randomized controlled trials

  2023cites this paper
• The effect of amiodarone on the spectral parameters of heart rate variability in patients with various forms of atrial fibrillation

  2023cites this paper
• The Relationship Between Atrial Fibrillation and Parathyroid Hormone in Heart Failure Outpatients.

  2023cites this paper
• Effectiveness of Catheter Ablation in Left Ventricular Ejection Fraction, Stroke, Quality of Life, All-Cause Mortality, Sinus Rhythm Maintenance, and Hospitalization Rates as Compared to Medical Therapy

  2023cites this paper
• Atrial Fibrillation in Heart Failure: Epidemiology, Quality of Life and Clinical Characteristics in the Iron Deficiency and ANaemia in Heart Failure (IDAN-HF) Study in Ogbomoso, Nigeria

  2023cites this paper
• Midazolam versus morphine in acute cardiogenic pulmonary edema patients with and without atrial fibrillation: findings from the MIMO trial

  2023cites this paper
• Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions

  2022cites this paper
• Value of echocardiography in evaluating efficacy of radiofrequency catheter ablation in patients with atrial fibrillation.

  2022cites this paper
• Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation

  2022cites this paper
• Left Atrial Myocardium in Arterial Hypertension

  2022cites this paper
• Prediction of herbal medicines based on immune cell infiltration and immune- and ferroptosis-related gene expression levels to treat valvular atrial fibrillation

  2022cites this paper
• Long-term Outcome of Repaired Tetralogy of Fallot: Survival, Tachyarrhythmia, and Impact of Pulmonary Valve Replacement.

  2022cites this paper
• Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF

  2021cites this paper
• Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD‐AF

  2021cites this paper
• Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

  2021cites this paper
• Prevalence, Mechanisms, and Management of Ischemic Stroke in Heart Failure Patients

  2021cites this paper
• Mendelian randomization study on atrial fibrillation and cardiovascular disease subtypes

  2021cites this paper
• Prevalence of sudden cardiac death in dogs with atrial fibrillation

  2021cites this paper
• Characteristics of the Dynamic Electrocardiogram in the Elderly with Nonvalvular Atrial Fibrillation Combined with Long R-R Intervals

  2021cites this paper
• Atrial fibrillation in patients with heart failure with preserved ejection fraction.

  2020cites this paper
• Effect of sotalol on heart rate variability in patients with atrial fibrillation (clinical observation)

  2020cites this paper
• Heart rhythm during episodes of collapse in boxers with frequent or complex ventricular ectopy.

  2020cites this paper
• Na/Ca exchange in the atrium: Role in sinoatrial node pacemaking and excitation-contraction coupling.

  2020cites this paper
• The Role of Sleep Disturbance, Depression and Anxiety in Frail Patients with AF–Gender Differences

  2020cites this paper
• Impact of catheter ablation in patients with atrial flutter and concurrent heart failure

  2020cites this paper
• Meta-Analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction.

  2020cites this paper
• Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation

  2020cites this paper
• Влияние соталола на вариабельность сердечного ритма у пациентов с фибрилляцией предсердий (клиническое наблюдение)

  2020cites this paper
• Efficacy and safety of non-vitamin K anticoagulants and warfarin in patients with atrial fibrillation and heart failure: A network meta-analysis.

  2020cites this paper
• Hydrogen-rich saline mitigates pressure overload-induced cardiac hypertrophy and atrial fibrillation in rats via the JAK-STAT signalling pathway

  2020cites this paper
• The ABCs of atrial fibrillation.

  2020cites this paper
• The ABCs of atrial fibrillation.

  2020cites this paper
• СПЕКТРАЛЬНЫЙ АНАЛИЗ ВАРИАБЕЛЬНОСТИ СЕРДЕЧНОГО РИТМА У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ НА ФОНЕ ПРИМЕНЕНИЯ СОТАЛОЛА И БИСОПРОЛОЛА

  2020cites this paper
• Atrial fibrillation in the elderly: A risk factor beyond stroke.

  2020cites this paper
• Triggered Ca2+ Waves Induce Depolarization of Maximum Diastolic Potential and Action Potential Prolongation in Dog Atrial Myocytes

  2020cites this paper
• Catheter ablation of atrial fibrillation in heart failure: clinical, prognostic, and echocardiographic outcome

  2020cites this paper
• Effect of amiodarone on heart rate variability in patients with newly diagnosed atrial fibrillation (clinical observation)

  2020cites this paper
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.

  2019cites this paper
• INFLUENCE OF ANTIARRHYTHMIC DRUGS ON THE SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION

  2018cites this paper
• AV Nodal Ablation in Heart Failure Patients with Atrial Fibrillation

  2018cites this paper
• Heart Failure as a Risk Factor for Stroke

  2018cites this paper
• Atrial Fibrillation in Congestive Heart Failure: Two Winding Roads Leading to a Profound Precipice

  2018cites this paper
• Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

  2018cites this paper
• Scholarly Commons @ Baptist Health South Florida Scholarly Commons @ Baptist Health South Florida

  year unknowncites this paper